Коллоиды: рекомендации по применению, литература

Ballinger WF II, Solanke TF, Thompson WL: Effect of hydroxyethyl starch upon survival of dogs subjected to hemorrhagic shock. Surg Gynecol Obstet 122:33, 1966. When hetastarch was infused, percentage of dogs that survived was greater than when dextran was given as a volume replacement fluid.

Boldt J, Mueller M, Heesen M, et al: Influence of different volume therapies and pentoxifylline infusion on circulating soluble adhesion molecules in critically ill patients. Crit Care Med 24:385, 1996. Long- term volume therapy with hydroxyethyl starch decreased plasma concentrations of soluble adhesion molecules, in contrast to albumin and pentoxifylline, which further increased their concentration.

Concannon KT, Haskins SC, Feldman BF: Hemostatic defects associated with two infusion rates of dextran 70 in dogs. Am J Vet Res 53:1369, 1992. Measurements of coagulation parameters in normal dogs receiving dextran 70.

Dextran 40. In: Sewester CS, Olin BR, Hebel SK, et al, eds: Drug Facts and Comparisons. St. Louis: Wolters Kluwer, 1996, p 93. Pharmacology of dextran 40, its indications and uses.

Gold MS, Russo J, Tissot M, et al: Comparison of hetastarch to albumin for perioperative bleeding in patients undergoing abdominal aortic aneurysm repair: A prospective, randomized study. Ann Surg 211:482,1990.

Kaufman BS: Fluid resuscitation of the critically ill. Crit Care Clin 8:235, 1992. A practical guide to the use of various fluid types in critically ill people.

Zikria BA, Subbarao C, Oz MC, et al: Macromolecules reduce abnormal microvascular permeability in rat limb ischemia-reperfusion injury. Crit Care Med 17:1306, 1989. Reduction of abnormally increased microvascular permeability may be accomplished by appropriately sized intravenous hydroxyethyl starch molecules.

Ссылки: